Role of F1C Fimbriae, Flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 1801-1812

  Kleta, Sylvia ^a   Nordhoff, Marcel ^a   Tedin, Karsten ^a   Wieler, Lothar H ^a   Kolenda, Rafal ^b,c   Oswald, Sibylle ^d   Oelschlaeger, Tobias A ^d   Bleiß, Wilfried ^e   Schierack, Peter ^a,c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL FLAGELLUM; BACTERIUM ADHERENCE; BACTERIUM COLONY; COLONY FORMATION; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI NISSLE 1917; FIMBRIA; GROWTH; HOST CELL; HUMAN; INTESTINE EPITHELIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BACTERIAL ADHESION; CELL LINE; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; FLAGELLA; GENE EXPRESSION REGULATION, BACTERIAL; INTESTINAL MUCOSA; PROBIOTICS; SWINE; VIRULENCE;

EID: 84898866891     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01431-13     Document Type: Article

References (66)

1. Bertschinger HU, Fairbrother JM. 1999. Escherichia coli infections, p 431-468. In Straw BE, D'Allaire S, Mengeling WL, Taylor DJ (ed), Diseases of swine, 8th ed. Blackwell Science, Oxford, United Kingdom.
2. Zhu C, Harel J, Jacques M, Desautels C, Donnenberg MS, Beaudry M, Fairbrother JM. 1994. Virulence properties and attaching-effacing activity of Escherichia coli O45 from swine postweaning diarrhea. Infect. Immun. 62:4153-4159.
3. Clarke SC. 2001. Diarrhoeagenic Escherichia coli-an emerging problem? Diagn. Microbiol. Infect. Dis. 41:93-98. http://dx.doi.org/10.1016/S0732 -8893(01)00303-0.
4. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
5. Ochoa TJ, Barletta F, Contreras C, Mercado E. 2008. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans. R. Soc. Trop. Med. Hyg. 102:852-856. http://dx.doi.org/10.1016/j.trstmh.2008.03.017.
6. Trabulsi LR, Keller R, Tardelli Gomes TA. 2002. Typical and atypical enteropathogenic Escherichia coli. Emerg. Infect. Dis. 8:508-513. http://dx.doi.org/10.3201/eid0805.010385.
7. Aktan I, Sprigings KA, La Ragione RM, Faulkner LM, Paiba GA, Woodward MJ. 2004. Characterisation of attaching-effacing Escherichia coli isolated from animals at slaughter in England and Wales. Vet. Microbiol. 102:43-53. http://dx.doi.org/10.1016/j.vetmic.2004.04.013.
8. Krause G, Zimmermann S, Beutin L. 2005. Investigation of domestic animals and pets as a reservoir for intimin-(eae) gene positive Escherichia coli types. Vet. Microbiol. 106:87-95. http://dx.doi.org/10.1016/j.vetmic.2004.11.012.
9. Moura RA, Sircili MP, Leomil L, Matte MH, Trabulsi LR, Elias WP, Irino K, Pestana de Castro AF. 2009. Clonal relationship among atypical enteropathogenic Escherichia coli strains isolated from different animal species and humans. Appl. Environ. Microbiol. 75:7399-7408. http://dx.doi.org/10.1128/AEM.00636-09.
10. Cleary J, Lai LC, Shaw RK, Straatman-Iwanowska A, Donnenberg MS, Frankel G, Knutton S. 2004. Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of bundle-forming pili (BFP), EspA filaments and intimin. Microbiology 150:527-538. http://dx.doi.org /10.1099/mic.0.26740-0.
11. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520. http://dx.doi.org/10.1016/S0092-8674(00)80437-7.
12. Knutton S, Rosenshine I, Pallen MJ, Nisan I, Neves BC, Bain C, Wolff C, Dougan G, Frankel G. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166-2176. http://dx.doi.org/10.1093/emboj /17.8.2166.
13. Moon HW, Whipp SC, Argenzio RA, Levine MM, Giannella RA. 1983. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect. Immun. 41:1340-1351.
14. Henker J, Laass MW, Blokhin BM, Maydannik VG, Bolbot YK, Elze M, Wolff C, Schreiner A, Schulze J. 2008. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr. Infect. Dis. J. 27:494-499. http://dx.doi.org /10.1097/INF.0b013e318169034c.
15. Krammer HJ, Kamper H, von Bunau R, Zieseniss E, Stange C, Schlieger F, Clever I, Schulze J. 2006. Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients. Z. Gastroenterol. 44:651-656. (In German.). http://dx.doi.org /10.1055/s-2006-926909.
16. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617-1623. http://dx.doi.org/10.1136/gut.2003.037747.
17. Schroeder B, Duncker S, Barth S, Bauerfeind R, Gruber AD, Deppenmeier S, Breves G. 2006. Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig. Dis. Sci. 51:724-731. http://dx.doi.org/10.1007/s10620 -006-3198-8.
18. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Gottl C, Dunger N, Grunwald N, Scholmerich J, Rath HC. 2004. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin. Diagn. Lab. Immunol. 11:372-378. http://dx.doi.org/10.1128/CDLI.11.2.372-378.2004.
19. von Buenau R, Jaekel L, Schubotz E, Schwarz S, Stroff T, Krueger M.2005. Escherichia coli strain Nissle 1917: significant reduction of neonatal calf diarrhea. J. Dairy Sci. 88:317-323. http://dx.doi.org/10.3168/jds.S0022-0302(05)72690-4.
20. Arribas B, Rodriguez-Cabezas ME, Camuesco D, Comalada M, Bailon E, Utrilla P, Nieto A, Concha A, Zarzuelo A, Galvez J. 2009. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br. J. Pharmacol. 157:1024-1033. http://dx.doi.org/10.1111/j.1476-5381.2009.00270.x.
21. Bar F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, Sonnenborn U, Bottner M, Wedel T. 2009. Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol. Motil. 21:559-566. http://dx.doi.org/10.1111/j.1365-2982.2008.01258.x.
22. Bickert T, Trujillo-Vargas CM, Duechs M, Wohlleben G, Polte T, Hansen G, Oelschlaeger TA, Erb KJ. 2009. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int. Arch. Allergy Immunol. 149:219-230. http://dx.doi.org/10.1159/000199717.
23. Helwig U, Lammers KM, Rizzello F, Brigidi P, Rohleder V, Caramelli E, Gionchetti P, Schrezenmeir J, Foelsch UR, Schreiber S, Campieri M. 2006. Lactobacilli, bifidobacteria and E. coli Nissle induce pro-and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J. Gastroenterol. 12:5978-5986.
24. Kamada N, Maeda K, Inoue N, Hisamatsu T, Okamoto S, Hong KS, Yamada T, Watanabe N, Tsuchimoto K, Ogata H, Hibi T. 2008. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect. Immun. 76:214-220. http://dx.doi.org/10.1128/IAI.01193-07.
25. Otte JM, Podolsky DK. 2004. Functional modulation of enterocytes by grampositive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G613-G626. http://dx.doi.org/10.1152/ajpgi.00341.2003.
26. Reissbrodt R, Hammes WP, dal Bello F, Prager R, Fruth A, Hantke K, Rakin A, Starcic-Erjavec M, Williams PH. 2009. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol. Lett. 290:62-69. http://dx.doi.org/10.1111/j.1574-6968.2008.01405.x.
27. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G, Suerbaum S, Buer J, Gunzer F, Westendorf AM. 2007. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2:e1308. http: //dx.doi.org/10.1371/journal.pone.0001308.
28. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA. 2007. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 9:804-816. http://dx.doi.org/10.1111/j.1462-5822.2006.00836.x.
29. Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA. 2004. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 40: 223-229. http://dx.doi.org/10.1016/S0928-8244(03)00368-7.
30. Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. 2003. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment. Pharmacol. Ther. 18:45-56. http://dx.doi.org/10.1046/j.1365-2036.2003.01638.x.
31. Schierack P, Nordhoff M, Pollmann M, Weyrauch KD, Amasheh S, Lodemann U, Jores J, Tachu B, Kleta S, Blikslager A, Tedin K, Wieler LH. 2006. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochem. Cell Biol. 125:293-305. http://dx.doi.org/10.1007/s00418-005-0067-z.
32. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
33. Knutton S, Baldwin T, Williams PH, McNeish AS. 1989. Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 57:1290-1298.
34. Kleta S, Steinrück H, Breves G, Duncker S, Laturnus C, Wieler LH, Schierack P. 2006. Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany. J. Appl. Microbiol. 101: 1357-1366. http://dx.doi.org/10.1111/j.1365-2672.2006.03019.x.
35. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. http://dx.doi.org/10.1038/227680a0.
36. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:4350-4354. http://dx.doi.org/10.1073/pnas.76.9.4350.
37. Patzer SI, Baquero MR, Bravo D, Moreno F, Hantke K. 2003. The colicin G,H and X determinants encode microcinsMand H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology 149:2557-2570. http://dx.doi.org/10.1099/mic.0.26396-0.
38. Duquesne S, Destoumieux-Garzon D, Peduzzi J, Rebuffat S. 2007. Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat. Prod. Rep. 24:708-734. http://dx.doi.org/10.1039/b516237h.
39. Ide T, Laarmann S, Greune L, Schillers H, Oberleithner H, Schmidt MA. 2001. Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell. Microbiol. 3:669-679. http://dx.doi.org/10.1046/j.1462 -5822.2001.00146.x.
40. Iizumi Y, Sagara H, Kabe Y, Azuma M, Kume K, Ogawa M, Nagai T, Gillespie PG, Sasakawa C, Handa H. 2007. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host. Microbe 2:383-392. http://dx.doi.org /10.1016/j.chom.2007.09.012.
41. Kenny B, Finlay BB. 1995. Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 92:7991-7995. http://dx.doi.org/10.1073/pnas.92.17.7991.
42. Schierack P, Kleta S, Tedin K, Babila JT, Oswald S, Oelschlaeger TA, Hiemann R, Paetzold S, Wieler LH. 2011. E. coli Nissle 1917 affects salmonella adhesion to porcine intestinal epithelial cells. PLoS One 6:e14712. http://dx.doi.org/10.1371/journal.pone.0014712.
43. Prilassnig M, Wenisch C, Daxboeck F, Feierl G. 2007. Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wien Klin. Wochenschr. 119:456-462. http://dx.doi.org/10.1007/s00508-007 -0808-1.
44. Boudeau J, Barnich N, Darfeuille-Michaud A. 2001. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol. Microbiol. 39:1272-1284. http://dx.doi.org/10.1111/j.1365-2958.2001.02315.x.
45. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. U. S. A. 93:9827-9832. http://dx.doi.org/10.1073/pnas.93.18.9827.
46. Blum G, Marre R, Hacker J. 1995. Properties of Escherichia coli strains of serotype O6. Infection 23:234-236. http://dx.doi.org/10.1007 /BF01781204.
47. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Dobrindt U. 2004. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 186:5432-5441. http://dx.doi.org/10.1128/JB.186.16.5432-5441.2004.
48. Monteiro C, Saxena I, Wang X, Kader A, Bokranz W, Simm R, Nobles D, Chromek M, Brauner A, Brown RM, Jr, Romling U. 2009. Characterization of cellulose production in Escherichia coli Nissle 1917 and its biological consequences. Environ. Microbiol. 11:1105-1116. http://dx.doi.org/10.1111/j.1462-2920.2008.01840.x.
49. Lasaro MA, Salinger N, Zhang J, Wang Y, Zhong Z, Goulian M, Zhu J. 2009. F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl. Environ. Microbiol. 75:246-251. http://dx.doi.org/10.1128/AEM.01144-08.
50. Ramos HC, Rumbo M, Sirard JC. 2004. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 12:509-517. http://dx.doi.org/10.1016/j.tim.2004.09.002.
51. Giron JA, Torres AG, Freer E, Kaper JB. 2002. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol. Microbiol. 44: 361-379. http://dx.doi.org/10.1046/j.1365-2958.2002.02899.x.
52. Ukena SN, Westendorf AM, Hansen W, Rohde M, Geffers R, Coldewey S, Suerbaum S, Buer J, Gunzer F. 2005. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med. Genet. 6:43. http://dx.doi.org/10.1186/1471-2350-6-43.
53. Ofek I, Doyle RJ. 1994. Bacterial adhesion to cells and tissues. Chapman & Hall, New York, NY.
54. Collado MC, Meriluoto J, Salminen S. 2007. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol. 45:454-460. http://dx.doi.org/10.1111/j.1472-765X.2007.02212.x.
55. Mack DR, Lebel S. 2004. Role of probiotics in the modulation of intestinal infections and inflammation. Curr. Opin. Gastroenterol. 20:22-26. http: //dx.doi.org/10.1097/00001574-200401000-00006.
56. Backhed F, Alsen B, Roche N, Angstrom J, von Euler A, Breimer ME, Westerlund-Wikstrom B, Teneberg S, Richter-Dahlfors A. 2002. Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation. J. Biol. Chem. 277:18198-18205. http://dx.doi.org/10.1074/jbc.M111640200.
57. Khan AS, Kniep B, Oelschlaeger TA, Van Die I, Korhonen T, Hacker J. 2000. Receptor structure for F1C fimbriae of uropathogenic Escherichia coli. Infect. Immun. 68:3541-3547. http://dx.doi.org/10.1128/IAI.68.6.3541-3547.2000.
58. Jagannatha HM, Sharma UK, Ramaseshan T, Surolia A, Balganesh TS. 1991. Identification of carbohydrate structures as receptors for localised adherent enteropathogenic Escherichia coli. Microb. Pathog. 11:259-268. http://dx.doi.org/10.1016/0882-4010(91)90030-E.
59. Fujiwara S, Hashiba H, Hirota T, Forstner JF. 1999. Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide. J. Appl. Microbiol. 86:615-621. http://dx.doi.org/10.1046/j.1365-2672.1999.00705.x.
60. Zhong SS, Zhang ZS, Wang JD, Lai ZS, Wang QY, Pan LJ, Ren YX. 2004. Competitive inhibition of adherence of enterotoxigenic Escherichia coli, enteropathogenic Escherichia coli and Clostridium difficile to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027. World J. Gastroenterol. 10:1630-1633.
61. Jarvis KG, Giron JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. U. S. A. 92:7996-8000. http://dx.doi.org/10.1073/pnas.92.17.7996.
62. Deng W, Li Y, Hardwidge PR, Frey EA, Pfuetzner RA, Lee S, Gruenheid S, Strynakda NC, Puente JL, Finlay BB. 2005. Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect. Immun. 73:2135-2146. http://dx.doi.org/10.1128/IAI.73.4.2135-2146.2005.
63. Kimura K, Iwatsuki M, Nagai T, Matsumoto A, Takahashi Y, Shiomi K, Omura S, Abe A. 2011. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. J. Antibiot. 64:197-203. http://dx.doi.org/10.1038/ja.2010.155.
64. Blattner FR, GPlunkett, III, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1462. http://dx.doi.org/10.1126/science.277.5331.1453.
65. Zingler G, Ott M, Blum G, Falkenhagen U, Naumann G, Sokolowska-Kohler W, Hacker J. 1992. Clonal analysis of Escherichia coli serotype O6 strains from urinary tract infections. Microb. Pathog. 12:299-310. http: //dx.doi.org/10.1016/0882-4010(92)90048-S.
66. Troge A, Scheppach W, Schroeder BO, Rund SA, Heuner K, Wehkamp J, Stange EF, Oelschlaeger TA. 2012. More than a marine propeller-the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. Int. J. Med. Microbiol. 302: 304-314. http://dx.doi.org/10.1016/j.ijmm.2012.09.004.